top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Molecular Pathways in Cancers
Molecular Pathways in Cancers
Autore Cristóbal Ion
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (284 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato actin cytoskeletal reorganization
breast cancer
CD99 agonist
EGFR dimerization
endocytosis
FAK dephosphorylation
PTPN12
Rac1
RhoA
tripeptide
OMD
PRELP
tumor suppression gene
bladder cancer initiation
tight junction
partial EMT
tousled-like kinase (TLK)
NIMA-related kinase 1 (NEK1)
yes-associated protein 1 (YAP1)
thioridazine (THD)
MS-determined phosphopeptides
human immunodeficiency virus type 1
epithelial cells
carcinogenicity
oxidative stress
reactive oxygen species
gp120
Tat
Nef
matrix protein p17
reverse transcriptase
mitochondria
metastasis
OXPHOS
cancer
Warburg effect
cancer therapeutics
myeloproliferative neoplasms
signaling pathways
JAK2
CALR
MPL
TPOR
DUSP1
MAPK
Snail
prostate cancer
migration and invasion
patient survival
biomarkers
pBRD4
SET
PP2A
prognosis
triple negative breast cancer
resistance
anti-receptor therapy
trastuzumab
PI3K
mTOR
TAK-228
epigenetic
methylation
acetylation
non-coding RNA
small-cell lung cancer
triple-negative breast cancer
pancreatic ductal adenocarcinoma
glioblastoma
metastatic melanoma
advanced ovarian cancer
hepatocellular carcinoma
immune evasion
immunotherapy
immune checkpoint inhibitors
oncogenic signaling pathway
molecular targeted agents
genome
epigenome
tumor immune microenvironment
ovarian cancer
adaptive immunity
innate immunity
complement system
cancer immunology
tumor microenvironment
splicing pathway
luminal breast cancer
BET inhibitors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566473703321
Cristóbal Ion  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Small Cell Lung Cancer: A New Era Is Beginning?
Small Cell Lung Cancer: A New Era Is Beginning?
Autore Morabito Alessandro
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (150 p.)
Soggetto topico Medicine
Soggetto non controllato immune checkpoint inhibitors
extensive-stage small cell lung cancer
nivolumab
ipilimumab
pembrolizumab
atezolizumab
durvalumab
chemotherapy
small-cell lung cancer
lobectomy
pneumonectomy
radiotherapy
multimodal treatment
immunotherapy
SCLC
PARP
DDR
ICB
synthetic lethality
SLFN11
STING
pathology and classification of SCLC
biology of SCLC
immune-checkpoint inhibitors in SCLC
small cell lung cancer
Immunotherapy
extensive disease
lurbinectedin
gene pathway
pathobiology
targeted therapy
circulating tumor cells
prognostic biomarker
targeted agents
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Small Cell Lung Cancer
Record Nr. UNINA-9910557380603321
Morabito Alessandro  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui